文献速递皮肤肿瘤

局限性皮肤黑色素瘤幸存者的生活体验与癌症复发恐惧

Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
PubMed 文献 · JAMA Dermatol · 2024-01-01

该定性与问卷调查纳入51例局限性皮肤黑色素瘤(0-IIA期)幸存者,通过半结构化访谈和癌症复发恐惧量表简表(FCRI-SF)评估。访谈揭示围绕随访的情绪、监测强度、防晒生活方式改变及生死思考四大主题;

要点

  • 局限性黑色素瘤幸存者中癌症复发恐惧普遍存在,FCRI-SF评分超阈值者占多数。
  • 即使0期患者也存在强烈幸存者体验,影响心理 wellbeing。
  • 随访相关情绪、监测强度、防晒改变和生死思考是主要生活体验主题。

核心结论

  • 尽管局限性黑色素瘤预后良好,部分幸存者(包括0期)仍有高比例的癌症复发恐惧和强烈的幸存者体验,影响心理健康。

研究设计与样本

  • 定性与问卷调查相结合的研究,采用半结构化访谈和FCRI-SF量表,从德克萨斯大学奥斯汀分校附属学术皮肤科诊所招募参与者。
  • 共51例有局限性黑色素瘤(0-IIA期)病史的参与者完成访谈和调查,平均年龄49.5岁(SD 11.7),女性34例(67%),男性17例(33%)。

主要发现

  • 访谈揭示四个主题:围绕随访预约的情绪、黑色素瘤监测的强度、关于日晒的生活方式改变、对生与死的思考。

关键数值与推荐

  • FCRI-SF共9个条目,每项按5点Likert量表评分(0-4分),最高可能得分36分。
  • FCRI-SF评分≥13分认定为潜在临床显著癌症复发恐惧病例。
  • 51例中17例(33%)为0期黑色素瘤幸存者,其余至少有一次侵袭性黑色素瘤诊断(I-IIA期)。

临床怎么用

  • 皮肤科医生应关注局限性黑色素瘤幸存者的心理 wellbeing,尤其对FCRI-SF评分≥13分者考虑进一步心理评估。
  • 随访沟通中需注意患者围绕随访预约的情绪反应,并识别监测强度、防晒改变和生死思考等体验主题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Most of the rapid increase in cutaneous melanoma incidence in the US has been localized disease that is treated surgically and is associated with high survival rates. However, little is known about the psychological well-being of survivors in the US. OBJECTIVE: To explore the lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma. DESIGN, SETTING, AND PARTICIPANTS: This was a qualitative and survey-based study that used semistructured interviews and the Fear of Cancer Recurrence Inventory short form (FCRI-SF) survey tool with participants recruited from an academic dermatology practice affiliated with the University of Texas, Austin. Interviews were completed via telephone or in person from August 2021 to September 2022. Each of the 9 items in the FCRI-SF was rated on a 5-point Likert scale, scored from 0 to 4, with a maximum possible score of 36 points. Data analyses were performed from February 2022 to June 2023. MAIN OUTCOMES AND MEASURES: Semistructured interviews were analyzed for themes and subthemes associated with the lived experiences of survivors of cutaneous melanoma. The FCRI-SF scores were tabulated, with scores of 13 or greater identifying potential cases of clinically significant fear of cancer recurrence. RESULTS: In all, 51 participants (mean [SD] age, 49.5 [11.7] years; 34 [67%] female and 17 [33%] male) with a history of localized melanoma (stage 0-IIA) completed the interview and survey. Among them, 17 (33%) had survived a diagnosis of stage 0 melanoma, and the remainder, at least 1 invasive melanoma diagnosis (stage I-IIA). Semistructured interviews revealed several themes: (1) emotions surrounding follow-up appointments, (2) intensity of melanoma surveillance, (3) lifestyle changes regarding sun exposure, and (4) thoughts about life and death. Thirty-eight of 51 participants had an FCRI-SF score above the threshold for clinical fear of cancer recurrence. CONCLUSIONS AND RELEVANCE: This qualitative and survey-based study found that despite having an excellent prognosis, some survivors of localized melanoma, even those who had stage 0, have high rates of fear of cancer recurrence and intense survivorship experiences that affect their psychological well-being.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Mahama AN, Haller CN, Labrada J, et al. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma. JAMA Dermatol. 2024. PMID: 38353983. doi:10.1001/jamadermatol.2023.6158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。